Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (4078P0_198363, 31CA30_196197)
Received: 2 December 2021
Accepted: 2 March 2022
First Online: 18 March 2022
: This study was approved by the Ethics Committee of the Canton of Geneva (No. 2020-01330). Each study participant of the seroprevalence survey provided written informed consent.
: Not applicable.
: All authors have no conflicts of interest to declare.